Document Detail

Induction of Cell Death in Renal Cell Carcinoma With Combination of D-Fraction and Vitamin C.
MedLine Citation:
PMID:  23341484     Owner:  NLM     Status:  Publisher    
Hypothesis. Although several conventional therapeutic options for advanced renal cell carcinoma (RCC) are currently available, the unsatisfactory outcomes demand establishing more effective interventions. D-fraction (PDF), a bioactive proteoglucan of Maitake mushroom, demonstrates anticancer and immunomodulatory activities, which are also shown to be potentiated by vitamin C (VC). We thus hypothesized that a combination of PDF and VC (PDF + VC) could be an alternative approach to more effectively inhibit the growth of RCC. STUDY DESIGN: We examined the dose-dependent effects of PDF + VC on RCC cell viability and also performed biochemical assays to explore the growth regulatory mechanism. METHODS: Human RCC, ACHN cell line, was employed and exposed to varying concentrations of PDF or VC and their combinations. Cell viability at specified times was determined by MTT assay. Lipid peroxidation assay, cell cycle analysis, and Western blot analysis were also performed. RESULTS: PDF or VC alone led to the significant reduction in cell viability at 72 hours with PDF >500 µg/mL and VC ≥300 µM. When various combinations of PDF and VC were tested, the combination of the ineffective concentrations of PDF (300 µg/mL) and VC (200 µM) resulted in ∼90% cell death in 24 hours. Lipid peroxidation assay then indicated significantly (∼2.5 fold) elevated oxidative stress with this PDF + VC. Cell cycle analysis also indicated a G(1) cell cycle arrest following a 6-hour PDF + VC treatment. Western blots further revealed a downregulation of Bcl2, an upregulation of Bax, and proteolytic activation of PARP (poly[ADP-ribose] polymerase) in PDF + VC-treated cells, indicating induction of apoptosis. CONCLUSION: The present study demonstrates that the combination of PDF and VC can become highly cytotoxic, inducing severe cell death in ACHN cells. This cytotoxic mechanism appears to be primarily attributed to oxidative stress, accompanied by a G(1) cell cycle arrest. Such cell death induced by PDF + VC could be more likely linked to apoptosis, as indicated by the modulation of apoptosis regulators (Bcl2, Bax, and PARP). Therefore, as PDF and VC may work synergistically to induce apoptotic cell death, they may have clinical implications in an alternative, improved therapeutic modality for advanced RCC.
Bobby Alexander; Andrew I Fishman; Majid Eshghi; Muhammad Choudhury; Sensuke Konno
Related Documents :
24445774 - Arginine-chitosan- and arginine- polyethylene glycol-conjugated superparamagnetic nanop...
25064634 - Reactive oxygen and nitrogen (ros and rns) species generation and cell death in tomato ...
24669904 - Low-solubility particles and a trojan-horse type mechanism of toxicity: the case of cob...
24582574 - Regulation of pluripotent cell differentiation by a small molecule, staurosporine.
21166884 - Different responses between diploid and tetraploid h1 embryonic stem cells appeared dur...
20164174 - Impairment of embryonic cell division and glycosaminoglycan biosynthesis in glucuronylt...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Integrative cancer therapies     Volume:  -     ISSN:  1552-695X     ISO Abbreviation:  Integr Cancer Ther     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101128834     Medline TA:  Integr Cancer Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
New York Medical College, Valhalla, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guidelin...
Next Document:  Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.